University of Pittsburgh
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).
University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.
University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,238 total, page 13 of 25
RCT: Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury
NCT02209935
Measuring the Context of Healing in Chronic Pain Treatment
NCT02873429
Prospective Study of Voice Therapy in Children: A Pilot Study
NCT02217111
Role of NGS-based ThyroSeq Panel in Cancer Diagnosis in Thyroid Nodules
NCT02352766
Effect of a Technology-Based Intervention on Weight Change Post-Bariatric Surgery
NCT02867696
Gas Supply, Demand and Middle Ear Gas Balance -- Fly/Dive Simulation
NCT01976429
An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence
NCT02296970
Comparison of Treatments Following Total Knee Replacement
NCT02237911
Dialectical Behavior Therapy (DBT) for Adolescents With Bipolar Disorder
NCT02003690
Procalcitonin Antibiotic Consensus Trial (ProACT)
NCT02130986
Comparison of DSM-IV-TR and DSM-5 for ASD
NCT02296502
[11C]NOP-1A and Cocaine Use Disorders
NCT03348384
Structural Fat Grafting for Craniofacial Trauma Using Manual Technique for Processing Fat Graft Material
NCT02267187
Physiologic Range of Step-by-step Variations in Lower Limb Prosthesis Forces During Walking
NCT02234505
Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes
NCT02238327
CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
NCT02058953
Person-Centered Versus Measurement-Based Care in Mental Health
NCT02507349
Hypoglycemia in Hospitalized Patients
NCT02228642
Using Smartphones to Enhance the Treatment of Childhood Anxiety
NCT02259036
Long Term Patency Following Arterial Repair
NCT02228057
Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis
NCT02203942
The Safety of High Dose Minocycline in the Patient Population Undergoing Carotid Revascularization
NCT02178813
The Healing Context in Complementary and Alternative Medicine (CAM): Initial Validation Study
NCT02161887
Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair
NCT02168439
A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device
NCT02141191
Trauma Services Intervention to Prevent Violence
NCT02642224
Optimization of the ex Vivo Challenge
NCT02134535
Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis
NCT02075918
Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer
NCT02124681
Balloon Dilation in Selected Subjects With Refractory Eustachian Tube Dysfunction
NCT02114762
Efficacy of Parent-Child Interaction Therapy With Autism Spectrum Disorder
NCT02088905
Consumer Engagement to Increase Advance Care Planning
NCT02208947
Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury
NCT02657135
SmartCare: Innovations in Caregiving Interventions
NCT02058745
COMMunication and Education for the New CPAP Experience
NCT01377584
Approaches and Decisions for Acute Pediatric TBI Trial
NCT04077411
Blended Collaborative Care for Heart Failure and Co-Morbid Depression
NCT02044211
Brief Intervention for Suicide Risk Reduction in High Risk Adolescents
NCT02272179
Translation Evaluation of Aging, Inflammation and HIV in Lung Function (TEAL)
NCT02154880
Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy
NCT02034305
Reducing Sedentary Behavior vs. Increasing Physical Activity in Older Adults
NCT02146001
Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain
NCT02055443
The Four Supports Study: Family Support Intervention in Intensive Care Units
NCT01982877
SleepTrackTXT Feasibility and Pilot Study
NCT02063737
On the Move: Optimizing Participation in Group Exercise
NCT01986647
Cepheid Rectal Sample Validation Study
NCT02099760
Adapting Daily Activity Performance Through Strategy Training
NCT01934621
Fat Grafting for Pedal Fat Pad Atrophy in Diabetics
NCT02074683
Computer-Based Weight Maintenance in Primary Care
NCT01946191
Gas Supply, Demand and Middle Ear Gas Balance -- Preliminary Protocol
NCT01955486
What is open in the University of Pittsburgh pipeline
160 recruiting of 1,238 indexed (13% open); 917 completed (74%).
Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Pittsburgh: open-pipeline peers nationwide
Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,238 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Intermountain Health Care · 13% recruiting · 85 trials
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- Temple University · 13% recruiting · 163 trials
Related
What to do with this University of Pittsburgh page
1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.
- 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.